Trials / Terminated
TerminatedNCT05924945
Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms
Impact of Bridge™ Device as a Non-pharmacological Approach to Treat Opioid Withdrawal in Opioid Use Disorder (OUD) Subjects in an Inpatient Treatment Center
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this prospective study is to investigate the efficacy of the Bridge™ device in reducing the symptoms of opioid withdrawal in a blind comparison to a sham device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bridge™ active device | Bridge is a percutaneous nerve field stimulation device |
| DEVICE | Bridge™ sham device | The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses. |
Timeline
- Start date
- 2023-06-08
- Primary completion
- 2024-08-19
- Completion
- 2024-08-19
- First posted
- 2023-06-29
- Last updated
- 2025-10-28
- Results posted
- 2025-10-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05924945. Inclusion in this directory is not an endorsement.